The Impact of COVID-19 on the Health-Care Workforce: from Heroes to Zeroes?

Por Czernin, Johannes
Publicado no J Nucl Med (2020)

Is conflict of interest in our best interest?

Por Beyer, Thomas, Czernin, Johannes
Publicado em 2010

The Potential of PET/MRI Imaging in Oncology: a Comment to a Summary Report of the First PET/MRI Workshop in Tuebingen in 2012

Por Czernin, Johannes, Herrmann, Ken
Publicado em 2013

A Conversation Between Nora Volkow and Johannes Czernin

Por Volkow, Nora, Czernin, Johannes
Publicado no J Nucl Med (2019)

Molecular Mechanisms of Bone (18)F-NaF Deposition

Por Czernin, Johannes, Satyamurthy, Nagichettiar, Schiepers, Christiaan
Publicado em 2010

(18)F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients

Por Spick, Claudio, Herrmann, Ken, Czernin, Johannes
Publicado no J Nucl Med (2016)

PET Imaging of Prostate Cancer Using (11)C-Acetate

Por Czernin, Johannes, Benz, Matthias R., Allen-Auerbach, Martin S.
Publicado em 2009

Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer

Por Lee, Percy, Kupelian, Patrick, Czernin, Johannes, Ghosh, Partha
Publicado em 2012

The future of hybrid imaging—part 3: PET/MR, small-animal imaging and beyond

Por Beyer, Thomas, Freudenberg, Lutz S., Czernin, Johannes, Townsend, David W.
Publicado em 2011

The future of hybrid imaging—part 1: hybrid imaging technologies and SPECT/CT

Por Beyer, Thomas, Freudenberg, Lutz S., Townsend, David W., Czernin, Johannes
Publicado em 2011

The future of hybrid imaging—part 2: PET/CT

Por Beyer, Thomas, Townsend, David W., Czernin, Johannes, Freudenberg, Lutz S.
Publicado em 2011

PET/CT in Oncology: Current Status and Perspectives

Por Czernin, Johannes, Allen-Auerbach, Martin, Nathanson, David, Herrmann, Ken
Publicado em 2013

Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites

Por Fendler, Wolfgang Peter, Czernin, Johannes, Herrmann, Ken, Beyer, Thomas
Publicado no J Nucl Med (2016)

Positron Emission Tomography Reporter Genes and Reporter Probes: Gene and Cell Therapy Applications

Por Yaghoubi, Shahriar S., Campbell, Dean O., Radu, Caius G., Czernin, Johannes
Publicado em 2012

Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs

Por Weber, Wolfgang A, Czernin, Johannes, Phelps, Michael E, Herschman, Harvey R
Publicado em 2008

Stratification of Nucleoside Analog Chemotherapy Using 1-(2′-Deoxy-2′-(18)F-Fluoro-β-D-Arabinofuranosyl)Cytosine and 1-(2′-Deoxy-2′-(18)F-Fluoro-β-L-Arabinofuranosyl)-5-Methylcytos...

Por Lee, Jason T., Campbell, Dean O., Satyamurthy, Nagichettiar, Czernin, Johannes, Radu, Caius G.
Publicado em 2012

Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters

Por Wieder, Hinrich A, Lassmann, Michael, Allen-Auerbach, Martin S, Czernin, Johannes, Herrmann, Ken
Publicado em 2014

NI-68 (18)F-FDOPA PET IN TREATED LOW-GRADE GLIOMAS WITH NON-ENHANCING T2 CHANGES ON MRI IS PROGNOSTIC OF TUMOR PROGRESSION AND OVERALL SURVIVAL

Por Schwarzenberg, Johannes, Czernin, Johannes, Cloughesy, Timothy, Lai, Albert, Phelps, Michael, Chen, Wei
Publicado em 2014

Absolute Quantitation of Myocardial Blood Flow in Human Subjects with or without Myocardial Ischemia using Dynamic Flurpiridaz F 18 Positron Emission Tomography

Por Packard, René R. S., Huang, Sung-Cheng, Dahlbom, Magnus, Czernin, Johannes, Maddahi, Jamshid
Publicado no J Nucl Med (2014)

Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]

Por Calais, Jeremie, Czernin, Johannes, Fendler, Wolfgang P., Elashoff, David, Nickols, Nicholas G.
Publicado no BMC Cancer (2019)